Yitao Xue

Statistics

Publications

Citations

333

H-Index

Active since

2021

Affiliations

Affiliated Hospital of Shandong University of Traditional Chinese Medicine(Current)

Shandong First Medical University

Shandong University of Traditional Chinese Medicine

Yitao Xue is an author at Affiliated Hospital of Shandong University of Traditional Chinese Medicine specializing in pharmacology, cardiology, and anthracycline-induced cardiotoxicity.

ORCID

Publications per year

2021–2024

Publications

MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis

Lei Zhang, Cundong Fan, Qian Zhang et al. · Biomedicine & Pharmacotherapy · 2021 · 116 citations · Full text

Medicine, Cardiology, Pharmacology +17

Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway

Xiujuan Liu, Yanfei Lv, Wen‐Zhu Cui et al. · FEBS Open Bio · 2021 · 106 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Calycosin Alleviates Doxorubicin‐Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation

Lei Zhang, Cundong Fan, Huachen Jiao et al. · Oxidative Medicine and Cellular Longevity · 2022 · 49 citations · Full text

Medicine, Cardiology, Pharmacology +15

Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2/SLC7A11/GPX4 signaling pathway

Quancheng Han, Jingle Shi, Yiding Yu et al. · Frontiers in Pharmacology · 2024 · 29 citations · Full text

Medicine, Cardiology, Pharmacology +17

Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study

Xiao Hua Hou, Li Tian, Lei Zhou et al. · Virology Journal · 2021 · 19 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +13

1–5 of 6